Quidel Buys Businesses From RPS Diagnostics

San Diego-based diagnostic testing products maker Quidel Corporation announced this week that it has acquired the InflammaDry and AdenoPlus diagnostic businesses from RPS Diagnostics. Quidel said it would pay approximately $14M in cash for those product lines. InflammaDry and AdenoPlus are rapid, lateral-flow based, POC products for the detection of infectious and inflammatory diseases and conditions of the eye. Quidel said it will transfer the manufacturing of those two products to its San Diego facility in the near term.